New pill takes on Hard-to-Treat cancers in early human trial
NCT ID NCT06577987
First seen Oct 31, 2025 · Last updated Jun 12, 2026 · Updated 36 times
Summary
This early-phase study tests an experimental pill, CID-078, in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety and find the best dose. About 220 participants will take the drug by mouth, and researchers will monitor side effects and whether tumors shrink.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Comprehensive Cancer Centers of Nevada
RECRUITINGLas Vegas, Nevada, 89169, United States
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
NEXT Oncology
RECRUITINGSan Antonio, Texas, 78229, United States
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START Mountain
RECRUITINGWest Valley City, Utah, 84119, United States
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
-
UH Seidman Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.